Emergency department-based testing for xylazine and other novel psychoactive substances in Central Alabama: a feasibility study

Abstract Alabama, like other states in the Deep South, lacks comprehensive testing for novel psychoactive substances (NPS) and adulterants like xylazine, leaving gaps in the detection of drug supply changes. From August 2024 to July 2025, we implemented an active testing approach at an emergency dep...

Descrición completa

Detalles Bibliográficos

Principais autores:	William Bradford, Daniel Dye, Rebecca Jensen, Reed Bratches, Stacy Marshall, Ellen Eaton, Mary Figgatt, Whitney Taylor, Lauren A Walter, David Goodman-Meza, Stefan Kertesz, Karen S. Scott
Formato:	Artigo
Idioma:	Inglês
Publicado:	BMC 2026-01-01
Series:	Harm Reduction Journal
Assuntos:	Xylazine Fentanyl Opioid Cohort Adulterants Alabama
Acceso en liña:	https://doi.org/10.1186/s12954-026-01401-5
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!